GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Adjuvant Holdings Co Ltd (TSE:4929) » Definitions » Intrinsic Value: Projected FCF

Adjuvant Holdings Co (TSE:4929) Intrinsic Value: Projected FCF : 円445.98 (As of May. 07, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Adjuvant Holdings Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-07), Adjuvant Holdings Co's Intrinsic Value: Projected FCF is 円445.98. The stock price of Adjuvant Holdings Co is 円852.00. Therefore, Adjuvant Holdings Co's Price-to-Intrinsic-Value-Projected-FCF of today is 1.9.

The historical rank and industry rank for Adjuvant Holdings Co's Intrinsic Value: Projected FCF or its related term are showing as below:

TSE:4929' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.02   Med: 1.96   Max: 2.31
Current: 1.91

During the past 12 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Adjuvant Holdings Co was 2.31. The lowest was 1.02. And the median was 1.96.

TSE:4929's Price-to-Projected-FCF is ranked worse than
70.08% of 1230 companies
in the Consumer Packaged Goods industry
Industry Median: 1.135 vs TSE:4929: 1.91

Adjuvant Holdings Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Adjuvant Holdings Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adjuvant Holdings Co Intrinsic Value: Projected FCF Chart

Adjuvant Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 730.53 583.32 532.31 585.30 445.98

Adjuvant Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 445.98 - - -

Competitive Comparison of Adjuvant Holdings Co's Intrinsic Value: Projected FCF

For the Household & Personal Products subindustry, Adjuvant Holdings Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adjuvant Holdings Co's Price-to-Projected-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Adjuvant Holdings Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Adjuvant Holdings Co's Price-to-Projected-FCF falls into.



Adjuvant Holdings Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Adjuvant Holdings Co's Free Cash Flow(6 year avg) = 円-2.35.

Adjuvant Holdings Co's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar23)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-2.345+4487.147*0.8)/7.999
=445.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adjuvant Holdings Co  (TSE:4929) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Adjuvant Holdings Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=852.00/445.97979441273
=1.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adjuvant Holdings Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Adjuvant Holdings Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Adjuvant Holdings Co (TSE:4929) Business Description

Traded in Other Exchanges
N/A
Address
5-5-5 Shimoyamatedori, Chuo-ku, Hyogo Prefecture, Kobe City, JPN, 650-0011
Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd is engaged in the research, development, production, and sale of cosmetics in Japan. It offers skin care products, including cleansing products, facial cleansers, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeup, and body care products among other products.

Adjuvant Holdings Co (TSE:4929) Headlines

No Headlines